17 January 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant
Anna Bednarek
1ACEFG*, Marzena Laskowska 2E
DOI: 10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
Background
Functioning of the Immune System During Pregnancy
COVID-19 During Pregnancy and Breastfeeding
Recommendations for Vaccination of Adolescents and Adults in the Reproductive Period
Recommendations for Vaccination of Pregnant Women – Priorities and Prospects
Vaccinations Against COVID-19, Including Against Omicron Variants of SARS-CoV-2, Pregnant and Breastfeeding Women
The Role of the Doctor, Midwife, and Nurse in the Care of a Pregnant Woman Regarding Immunization
Future Directions
Conclusions
References
Table 1 Vaccinations are recommended for adolescents, adults, and women in the reproductive period [6,7,9].
| Type of vaccine | Indicated age of vaccination | Recommendations for vaccination according to local arrangements |
|---|---|---|
| VZV (; against chickenpox) | 11–18 years, adults | |
| MMR (against measles, mumps, and rubella) | 11–18, adults | |
| Hepatitis B | 11–18 years, adults | |
| Hepatitis A | 11–18 years, adults | |
| Flu | Adolescents, adults | |
| HPV (against human papillomavirus) | 11–12 years, adults | |
| dTpa (combined vaccine containing tetanus toxoid and reduced doses of diphtheria toxoid and acellular pertussis antigens) | 11–12 years, adults | |
| Meningococci group A, C, Y, W-135Meningococcal group B | 11–12 years | |
| VZV – ; MMR – measles, mumps, and rubella; HPV – human papillomavirus; dTpa – combined vaccine containing tetanus toxoid and reduced doses of diphtheria toxoid and acellular pertussis antigens. | ||